Literature DB >> 14647919

[Narcoleptic dogs. Significance for human narcolepsy].

J Schiefer1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14647919     DOI： 10.1007/s00115-003-1628-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN： 0028-2804            Impact factor:   1.214


× No keyword cloud information.
  10 in total

1.  Sleepy dogs don't lie: a genetic disorder informative about sleep.

Authors:  T S Kilduff
Journal:  Genome Res       Date:  2001-04       Impact factor: 9.043

Review 2.  Functions of the orexinergic/hypocretinergic system.

Authors:  Jyrki P Kukkonen; Tomas Holmqvist; Sylwia Ammoun; Karl E O Akerman
Journal:  Am J Physiol Cell Physiol       Date:  2002-12       Impact factor: 4.249

3.  CSF hypocretin/orexin levels in narcolepsy and other neurological conditions.

Authors:  B Ripley; S Overeem; N Fujiki; S Nevsimalova; M Uchino; J Yesavage; D Di Monte; K Dohi; A Melberg; G J Lammers; Y Nishida; F W Roelandse; M Hungs; E Mignot; S Nishino
Journal:  Neurology       Date:  2001-12-26       Impact factor: 9.910

4.  The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene.

Authors:  L Lin; J Faraco; R Li; H Kadotani; W Rogers; X Lin; X Qiu; P J de Jong; S Nishino; E Mignot
Journal:  Cell       Date:  1999-08-06       Impact factor: 41.582

5.  Breeding history of the Stanford colony of narcoleptic dogs.

Authors:  R Cederberg; S Nishino; W C Dement; E Mignot
Journal:  Vet Rec       Date:  1998-01-10       Impact factor: 2.695

6.  A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains.

Authors:  C Peyron; J Faraco; W Rogers; B Ripley; S Overeem; Y Charnay; S Nevsimalova; M Aldrich; D Reynolds; R Albin; R Li; M Hungs; M Pedrazzoli; M Padigaru; M Kucherlapati; J Fan; R Maki; G J Lammers; C Bouras; R Kucherlapati; S Nishino; E Mignot
Journal:  Nat Med       Date:  2000-09       Impact factor: 53.440

7.  The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity.

Authors:  L de Lecea; T S Kilduff; C Peyron; X Gao; P E Foye; P E Danielson; C Fukuhara; E L Battenberg; V T Gautvik; F S Bartlett; W N Frankel; A N van den Pol; F E Bloom; K M Gautvik; J G Sutcliffe
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-06       Impact factor: 11.205

8.  HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients.

Authors:  E Mignot; R Hayduk; J Black; F C Grumet; C Guilleminault
Journal:  Sleep       Date:  1997-11       Impact factor: 5.849

9.  Identification and functional analysis of mutations in the hypocretin (orexin) genes of narcoleptic canines.

Authors:  M Hungs; J Fan; L Lin; X Lin; R A Maki; E Mignot
Journal:  Genome Res       Date:  2001-04       Impact factor: 9.043

10.  Sleep fragmentation in canine narcolepsy.

Authors:  K I Kaitin; T S Kilduff; W C Dement
Journal:  Sleep       Date:  1986       Impact factor: 5.849
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.